DEDanielle Christinne Soares Do Egypto

Danielle Christinne Soares Do Egypto

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Danielle Christinne Soares Do Egypto has a total of 108 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Development and validation of entrustable professional activities (EPAs) for rheumatology training in Brazil: the Reuma-EPA project

    by Claudia Diniz Lopes Marques, Carlos Augusto Ferreira de Andrade, Carolina Müller, Danielle Egypto, Elaine Lira Medeiros, Fabíola Brasil B. Rodrigues, Jozelia Rêgo, Marcelo Pimenta, Maria José Pereira Vilar, Rina Dalva Neubarth, et al.

    Background: Competency-based medical education increasingly guides postgraduate training worldwide. However, rheumatology training in Brazil still lacks a nationally standardized framework to define and assess core professional activities. Entrustable professional activities (EPAs) address this gap by translating competencies into observable clinical practice and supporting supervision, assessment, and progressive autonomy. Objective: To develop and validate a national EPA framework for rheumatology training in Brazil and to present the conceptual and practical foundations supporting competency-based assessment in the specialty. Methods: The Reuma-EPA project was conducted by the Education Committee of the Brazilian Society of Rheumatology using a five-phase methodological approach: identification of core professional activities, drafting of preliminary EPAs, internal expert review, internal consistency analysis, and national validation through a two-round Delphi process. Rheumatology educators from accredited residency programs across Brazil evaluated each EPA for relevance, clarity, and suitability for independent execution at the end of training. Consensus was defined as at least 80% of responses rated as 4 or 5 on a five-point Likert scale. Results: Eleven EPAs were developed and validated, covering the full spectrum of rheumatology practice, including ethical and professional conduct, patient assessment, diagnostic reasoning, laboratory and imaging interpretation, outpatient and inpatient care, use of immunomodulatory therapies, procedural skills, patient safety, and education. Each EPA was mapped to supervision levels and developmental milestones, creating a comprehensive framework that integrates patient-safety considerations and suggested workplace-based assessment tools for Brazilian rheumatology training. Conclusion: The Reuma-EPA project establishes the first nationally validated EPA framework for rheumatology training in Brazil. By providing an actionable competency-based structure aligned with national regulatory standards, this initiative supports curricular harmonization, transparent assessment, and the progressive development of resident autonomy with patient safety as a central principle. This framework has the potential to strengthen rheumatology training nationally and may serve as a model for other specialties and healthcare systems.

  • Open Access

    Neuropathic pain and central sensitization in patients with rheumatoid arthritis attending a tertiary hospital

    by Maria Nathalia Gabriela Rocha Pontes de Oliveira, Débora de Jesus Sena, Ana Karla Guedes de Melo, Danielle C. Soares Egypto, Luís Fábio Barbosa Botelho, Alessandra de Sousa Braz

    Background: In rheumatoid arthritis (RA), the persistence of pain despite adequate inflammatory control may indicate the involvement of nociplastic and/or neuropathic pain (NP). Objective: To investigate the presence of central sensitization (CS) and/or NP in patients with RA. Methods: This descriptive, cross-sectional study used convenience sampling and included adult patients (≥ 18 years) with RA diagnosed according to the 2010 classification criteria of the American College of Rheumatology – ACR. The following instruments were applied: Central Sensitization Inventory (CSI), PainDETECT Questionnaire (PD-Q), and the 2010/2011 ACR criteria for fibromyalgia (FM), revised in 2016 (the latter applied only to patients with CSI ≥ 40). Descriptive and predictive analyses were conducted with a significance level of 5%. Results: A total of 113 patients were included (mean age 54.3 years; 93.81% female; mean disease duration 12.11 years). CS was identified in 59.29% of patients; among them, 47.76% met FM criteria, while 52.24% did not. Among patients with CS, 53.73% reported severe pain (Numeric Rating Scale, NRS), and 44.78% had high disease activity (Clinical Disease Activity Index, CDAI). CSI was a significant predictor of both NRS and CDAI in univariate ( p < 0.001) and multivariate analyses ( p = 0.037 and p = 0.009, respectively). According to PD-Q, 17.70% of patients had probable NP, and PD-Q scores were predictive of CDAI, NRS, and CSI ( p < 0.001). Among patients with CS, 26.87% also showed overlapping NP. Conclusions: A substantial proportion of RA patients presented with CS-related pain, even in the absence of FM, suggesting a mixed (“top-down and bottom-up”) nociplastic pain profile. Both CS and NP were associated with higher pain levels and increased disease activity. This is the first Brazilian study to characterize the coexistence of CS-related pain (with or without FM) and NP in RA, offering relevant insights for the clinical management of chronic pain in this population. These findings reinforce that routine screening and assessment of CS and NP should be an integral and continuous component of RA management, preceding therapeutic adjustments and extending throughout follow-up.


  • Open Access

    Recommendations on neurologic, cognitive, and psychiatric manifestations in patients with Sjögren’s disease by the Brazilian Society of Rheumatology

    by Fabiola Reis de Oliveira, Simone Appenzeller, Sandra Gofinet Pasoto, Marilena Leal Mesquita Silvestre Fernandes, Maria Lucia Lemos Lopes, Sonia Cristina de Magalhães Souza Fialho, Aysa Cesar Pinheiro, Laura Caldas dos Santos, Valeria Valim, Erica Vieira Serrano, et al.

    Background: Neurological and psychiatric manifestations occur in patients with primary Sjogren’s disease (SjD) with a wide-ranging clinical presentation, affecting quality of life, social participation, and prognosis. Despite this, neither central nor peripheral neurological symptoms are systematically evaluated in the context of autoimmunity or identified as manifestations of SjD. The EULAR Sjogren’s Syndrome Disease Activity Index (ESSDAI) covers only part of them in the neurological domain. Methods: We performed a systematic review of the diagnosis and prevalence of central, peripheral, and autonomic nervous system manifestations in primary SjD, following the recommendations proposed by the Cochrane Collaboration Handbook. Observational studies were included when their main issue was the diagnosis and the prevalence of the manifestations individually. We employed a generalized linear mixed model (GLMM) method with a random-effects model, and the results were computed using logit transformation, implemented through the ‘meta’ and ‘metafor’ packages in the R software (version 3.6.1). To present these recommendations, agreement among experts was investigated using the Delphi method in in-person meetings. Results: We propose ten recommendations regarding the investigation and management of neurological involvement in SjD that had 100% agreement among participants. Conclusion: These recommendations add to the literature on the clinical care of patients with SjD.


  • Open Access

    Recommendations on cutaneous and hematological manifestations of Sjögren’s disease by the Brazilian Society of Rheumatology

    by Alisson Pugliesi, Danielle Christinne Soares Do Egypto, Guilherme Duffles, Diego Ustárroz Cantali, Sandra Gofinet Pasoto, Fabiola Reis Oliveira, Valeria Valim, Maria Lucia Lemos Lopes, Samira Tatiyama Miyamoto, Marilena Leal Mesquita Silvestre Fernandes, et al.

    Sjogren’s disease (SjD) is an autoimmune disease that is characterized not only by the sicca symptoms it causes but also by its systemic nature, which is capable of several and not yet fully understood extraglandular manifestations. To gain a clearer understanding of these manifestations as well as a better practical approach, a panel of experts from the Brazilian Society of Rheumatology conducted a systematic review and meta-analysis on the identification of epidemiologic and clinical features of the extraglandular manifestations present in ESSDAI (EULAR Sjogren´s syndrome disease activity index), followed by a voting panel with recommendations for clinical practice. This publication is complementary to others already published and covers cutaneous and hematological manifestations, with prevalence data generated by a meta-analysis of 13 clinical or laboratory manifestations and 6 clinical management recommendations.


  • Open Access

    II Brazilian Society of Rheumatology consensus for lupus nephritis diagnosis and treatment

    by Edgard Torres dos Reis-Neto, Luciana Parente Costa Seguro, Emília Inoue Sato, Eduardo Ferreira Borba, Evandro Mendes Klumb, Lilian Tereza Lavras Costallat, Marta Maria das Chagas Medeiros, Eloisa Bonfá, Nafice Costa Araújo, Simone Appenzeller, et al.

    Objective: To develop the second evidence-based Brazilian Society of Rheumatology consensus for diagnosis and treatment of lupus nephritis (LN). Methods: Two methodologists and 20 rheumatologists from Lupus Comittee of Brazilian Society of Rheumatology participate in the development of this guideline. Fourteen PICO questions were defined and a systematic review was performed. Eligible randomized controlled trials were analyzed regarding complete renal remission, partial renal remission, serum creatinine, proteinuria, serum creatinine doubling, progression to end-stage renal disease, renal relapse, and severe adverse events (infections and mortality). The Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach was used to develop these recommendations. Recommendations required ≥82% of agreement among the voting members and were classified as strongly in favor, weakly in favor, conditional, weakly against or strongly against a particular intervention. Other aspects of LN management (diagnosis, general principles of treatment, treatment of comorbidities and refractory cases) were evaluated through literature review and expert opinion. Results: All SLE patients should undergo creatinine and urinalysis tests to assess renal involvement. Kidney biopsy is considered the gold standard for diagnosing LN but, if it is not available or there is a contraindication to the procedure, therapeutic decisions should be based on clinical and laboratory parameters. Fourteen recommendations were developed. Target Renal response (TRR) was defined as improvement or maintenance of renal function (±10% at baseline of treatment) combined with a decrease in 24-h proteinuria or 24-h UPCR of 25% at 3 months, a decrease of 50% at 6 months, and proteinuria < 0.8 g/24 h at 12 months. Hydroxychloroquine should be prescribed to all SLE patients, except in cases of contraindication. Glucocorticoids should be used at the lowest dose and for the minimal necessary period. In class III or IV (±V), mycophenolate (MMF), cyclophosphamide, MMF plus tacrolimus (TAC), MMF plus belimumab or TAC can be used as induction therapy. For maintenance therapy, MMF or azathioprine (AZA) are the first choice and TAC or cyclosporin or leflunomide can be used in patients who cannot use MMF or AZA. Rituximab can be prescribed in cases of refractory disease. In cases of failure in achieving TRR, it is important to assess adherence, immunosuppressant dosage, adjuvant therapy, comorbidities, and consider biopsy/rebiopsy. Conclusion: This consensus provides evidence-based data to guide LN diagnosis and treatment, supporting the development of public and supplementary health policies in Brazil.


  • Open Access

    Recommendations for evaluation and diagnosis of extra-glandular manifestations of primary Sjögren syndrome: results of an epidemiologic systematic review/meta-analysis and a consensus guideline from the Brazilian society of rheumatology (hepatic, gastrointestinal and pancreatic)

    by Virginia Fernandes Moça Trevisani, Aysa César Pinheiro, Sonia Cristina de Magalhães Souza Fialho, Marilena Leal Mesquita Silvestre Fernandes, Alisson Pugliesi, Sandra Gofinet Pasoto, Maria Lucia Lemos Lopes, Lissiane Karine Noronha Guedes, Samira Tatiyama Miyamoto, Laura Caldas dos Santos, et al.

    Sjogren's syndrome (SS) is an autoimmune disease characterized by lymphocytic infiltration of the exocrine glands and other organs, associated with sicca syndrome but also with systemic involvement with varying degrees of severity. Despite their importance, some systemic manifestations, mainly liver, gastrointestinal, and pancreatic are not routinely evaluated. To address these manifestations, the Sjögren's Syndrome Committee of the Brazilian Society of Rheumatology conducted a broad systematic review of the literature on studies investigating prevalence and diagnosis of these symptoms in Sjogren´s patients and made recommendations based on the findings. Agreement between the experts was achieved using the Delphi method. This is the second part of this guideline, providing 6 recommendations for liver, gastrointestinal, and pancreatic care of SS patients.


  • Open Access

    Recommendations for evaluation and diagnosis of extra-glandular manifestations of primary sjogren syndrome: results of an epidemiologic systematic review/meta-analysis and a consensus guideline from the Brazilian Society of Rheumatology (articular, pulmonary and renal)

    by Virginia Fernandes Moça Trevisani, Alisson Pugliesi, Sandra Gofinet Pasoto, Maria Lucia Lemos Lopes, Lissiane Karine Noronha Guedes, Samira Tatiyama Miyamoto, Marilena Leal Mesquita Silvestre Fernandes, Sonia Cristina de Magalhães Souza Fialho, Aysa César Pinheiro, Laura Caldas dos Santos, et al.

    Sjogren's Syndrome (SS) is an autoimmune disease characterized by lymphocytic infiltration of the exocrine glands and other organs, associated with sicca syndrome but also with systemic involvement with varying degrees of severity. Despite their importance, these systemic manifestations are not routinely evaluated and there is no homogenous approach to their diagnosis or evaluation. To close this gap, a panel of experts from the Brazilian Society of Rheumatology conducted a systematic review and meta-analysis on the identification of epidemiologic and clinical features of these manifestations and made recommendations based on the findings. Agreement between the experts was achieved using the Delphi method. The first part of this guideline summarizes the most important topics, and 11 recommendations are provided for the articular, pulmonary, and renal care of SS patients.


  • Open Access

    Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort

    by Marcelo M. Pinheiro, Gecilmara S. Pileggi, Adriana M. Kakehasi, Ana Paula M. Gomides Reis, Edgard Torres Reis-Neto, Mirhelen M. Abreu, Cleandro P. Albuquerque, Nafice C. Araújo, Ana Beatriz Bacchiega, Dante V. Bianchi, et al.

    Full Papers; Authors: M.M. Pinheiro, G.S. Pileggi, A.M. Kakehasi, A.P.M. Gomides Reis, E.T. Reis-Neto, M.M. Abreu, C.P. Albuquerque, N.C. Araújo, A.B. Bacchiega, D.V. Bianchi, B. Bica, E. Bonfa, E.F. Borba, D.C. Egypto Brito, D.C. Calderaro, Â.L. Pinto Duarte, R.C. Espírito Santo, P.R. Fernandes, M.P. Guimarães, K.W. Poti Gomes, G.G. Faustino Ilana, E.M. Klumb, C.D. Marques, A.K. Guedes De Melo, O.A. Monticielo, L.M. Mota, G.A. Munhoz, E.S. Paiva, H.L.A. Pereira, J.R. Provenza, S.L.E. Ribeiro, L.F. Rocha Jr, E.I. Sato, T. Skare, V.A. De Souza, V. Valim, M.V. Lacerda, R.M. Xavier, G.A. Ferreira